openPR Logo
Press release

mRNA Vaccines Market Expansion Supported by Advancements in Cancer Vaccine Development 2025 | Market Players: Azra Al, CureMetrix, Inc., ConcertAI, Immunai, MVision AI Inc.

07-03-2025 02:15 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

mRNA Vaccines Market

mRNA Vaccines Market

mRNA Vaccines and Therapeutics market size reached US$ 410 Million in 2024 and is expected to reach US$ 850.90 Million by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033. Global mRNA Vaccines and Therapeutics Market showed resilience

The latest mRNA Vaccines market research report from DataM Intelligence delivers a comprehensive analysis of the global mRNA Vaccines Market landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. By leveraging advanced analytics, technology trend mapping, and regulatory assessment, the report highlights emerging growth drivers, evolving care models, and investment opportunities. It equips stakeholders with strategic intelligence essential for navigating the complex healthcare ecosystem from clinical innovation to operational efficiency across the forecast period 2025-2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/mrna-vaccine-and-therapeutics-market?ophp

mRNA vaccines work by instructing cells to produce antigens that trigger immune responses, as seen in COVID-19 vaccines. The market is expanding rapidly beyond COVID-19 to address diseases such as cancer, Zika, and HIV, fueled by fast production, high efficacy, and increasing investment in next-generation vaccine platforms.

Comprehensive Insight into mRNA Vaccines Market Competitor Landscape:

Azra Al, CureMetrix, Inc., ConcertAI, Immunai, MVision AI Inc., Paige AI, Inc., Mindpeak GmbH, Imagene AI Ltd., Predictive Oncology, and Tempus, among others.

Important Industry Updates:

In January 2025, Esphera SynBio, a pre-clinical stage synthetic biology company, initiated a new project focused on improving the effectiveness of mRNA vaccines. Utilizing its proprietary technology, the company aims to engineer mRNA vaccines that direct patient cells to produce modified nanomedicines upon delivery, enhancing therapeutic impact and precision.

mRNA Vaccines Market Segments Overview:

By Product Type(Prophylactic Vaccines, Therapeutic Vaccines, Therapeutic Drugs)
By Application (Cancer, Infectious Diseases, Rare Genetic Diseases, Others)
By End-user (Hospitals & Clinics, Research Organization, Academic Institutes, Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/mrna-vaccine-and-therapeutics-market?ophp

Methodology and Scope:

This mRNA Vaccines Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for mRNA Vaccines Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=mrna-vaccine-and-therapeutics-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the mRNA Vaccines market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the mRNA Vaccines industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the mRNA Vaccines market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Vaccines Market Expansion Supported by Advancements in Cancer Vaccine Development 2025 | Market Players: Azra Al, CureMetrix, Inc., ConcertAI, Immunai, MVision AI Inc. here

News-ID: 4091368 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Human Milk Oligosaccharides (HMO) Market to Reach USD 255.15 Million by 2030 | Key Players: Nestlé, DuPont, Glycom, Jennewein | DataM Intelligence
United States Human Milk Oligosaccharides (HMO) Market to Reach USD 255.15 Milli …
Leander, Texas and Tokyo, Japan - Jan.13.2026 The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 850.5 million by 2030. The market is growing at a CAGR of 20.1% during the forecast period 2024-2031. Market growth is driven by rising demand for infant nutrition that closely mimics human breast milk, increasing awareness of
Soil Stabilization Market to Reach USD 31.3 Billion by 2031 | CAGR 5.2% | Asia-Pacific Leads with 39% Share | Key Players: Caterpillar Inc., AB Volvo, FAYAT Group, WIRTGEN Group, Carmeuse, Global Road Technology
Soil Stabilization Market to Reach USD 31.3 Billion by 2031 | CAGR 5.2% | Asia-P …
Market Overview The global soil stabilization market reached US$ 20.89 billion in 2022 and is projected to grow to US$ 31.3 billion by 2031, exhibiting a CAGR of 5.2% during the forecast period 2024-2031. The market's growth is being driven by increasing global investments in infrastructure development, coupled with a heightened focus on sustainability and environmentally responsible construction practices. Soil stabilization plays a critical role in enhancing soil strength and load-bearing
United States Carotenoids Market to Grow at 4.8% CAGR Through 2031, Driven by Rising Demand for Natural Colorants, Nutraceuticals & Eye Health Applications | DataM Intelligence
United States Carotenoids Market to Grow at 4.8% CAGR Through 2031, Driven by Ri …
Leander, Texas and Tokyo, Japan - Jan.13.2026 Carotenoids Market is predicted to reach a high CAGR of 4.8% during the forecast period (2024-2031). Market growth is driven by rising demand for natural colorants in food and beverages, increasing consumer awareness of antioxidant and eye health benefits, and growing applications in dietary supplements and pharmaceuticals. Advancements in extraction technologies, expanding use of carotenoids in functional foods, cosmetics, and animal feed, and rising preference
Nanosilver Market to Reach USD 6.3 Billion by 2030 | CAGR 19.5% | Asia-Pacific Leads with 40% Share | Key Players: Silvix, NanoMas Technologies, NovaCentrix, Nano Silver Manufacturing
Nanosilver Market to Reach USD 6.3 Billion by 2030 | CAGR 19.5% | Asia-Pacific L …
Nanosilver Market Overview The global nanosilver market reached US$ 1.5 billion in 2022 and is projected to grow to US$ 6.3 billion by 2030, registering a CAGR of 19.5% during the forecast period 2023-2030. Nanosilver's unique properties, including its ultra-small particle size, high electrical and thermal conductivity, and strong antibacterial characteristics, have driven its adoption across diverse applications. It is increasingly used in water and air purifiers, washing machines, hair dryers,

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,